Breaking News Instant updates and real-time market news.

MMSI

Merit Medical

$56.21

0.03 (0.05%)

04:55
06/13/19
06/13
04:55
06/13/19
04:55

Merit Medical management to meet with Piper Jaffray

Meetings to be held in San Francisco, CA on June 12 in Los Angeles, CA on June 13 hosted by Piper Jaffray.

  • 13

    Jun

MMSI Merit Medical
$56.21

0.03 (0.05%)

02/11/19
PIPR
02/11/19
NO CHANGE
Target $75
PIPR
Overweight
Piper sees 2018 deals pushing Merit Medical shares 'much higher'
Merit Medical Systems executed four transactions, including one partnership with NinePoint, in 2018, representing capital deployed of approximately $380M, or 13% of its market capitalization, Piper Jaffray analyst Matt O'Brien tells investors in a research note. The analyst says Piper is "big fans" of the deals, with Cianna his favorite given the revenue growth outlook, along with the earnings power it could bring. Collectively he believes the acquired assets will add nearly 200 basis points to Merit Medical's organic revenue growth in 2020 and drive earnings above consensus. This will become clearer to investors in the coming quarters, "pushing shares much higher compared to current levels," says O'Brien. He keeps an Overweight rating on Merit Medical Systems with a $75 price target.
03/25/19
PIPR
03/25/19
NO CHANGE
PIPR
Piper sees six 'quality' Med Tech names whose stocks haven't rallied
Medical Technology stocks have rebounded quickly in Q1 following a challenging Q4 of 2018 as the combination of solid year-end results and compelling outlooks for next year have led investors back into the names, Piper Jaffray analyst Matt O'Brien tells investors in a research note. The analyst, however, has identified six "quality" names that have not participated in the Q1 share appreciation, "despite consistently delivering beat-and-raises." The basket of stocks include Abiomed (ABMD), Merit Medical (MMSI), AtriCure (ATRC), Neuronetics (STIM), SeaSpine (SPNE) and Nuvectra (NVTR).
04/24/19
PIPR
04/24/19
NO CHANGE
Target $75
PIPR
Overweight
Piper calls Merit Medical a must own name after Q1 beat
After a "robust" start to 2019, Merit Medical Systems is a mid-cap name that investors need to own, Piper Jaffray analyst Matt O'Brien writes in a research note. He believes the company can deliver some of the best top- and bottom-line growth in med tech in the coming years. Revenue from the recently completed Cianna acquisition helped deliver some of the revenue upside in Q1, but the organic growth in the business remains strong, says O'Brien. He reiterates an Overweight rating on Merit Medical with a $75 price target and says the stock remains his favorite mid-cap name.
06/03/19
ADAM
06/03/19
NO CHANGE
Target $63
ADAM
Buy
Merit Medical weakness a buying opportunity, says Canaccord
Canaccord analyst Jason Mills noted Merit Medical shares were weak following President Trump's threat to impose a 5% tariff on all goods from Mexico. The company currently manufactures roughly $120M in annual product revenues out of Mexico but the analyst said the lack of details from the President and a presumption of a soft deadline of June 10th, has provided a compelling entry point for investors. Mills reiterated his Buy rating and $63 price target on Merit Medical shares.

TODAY'S FREE FLY STORIES

AAPL

Apple

$207.21

4.59 (2.27%)

, INTC

Intel

$51.36

1.1 (2.19%)

17:28
07/22/19
07/22
17:28
07/22/19
17:28
Periodicals
Apple may pay $1B or more for Intel patents, staff in chip unit deal, WSJ says »

Apple (AAPL) is in…

AAPL

Apple

$207.21

4.59 (2.27%)

INTC

Intel

$51.36

1.1 (2.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 30

    Jul

  • 03

    Aug

ATVI

Activision Blizzard

$45.57

0.43 (0.95%)

17:26
07/22/19
07/22
17:26
07/22/19
17:26
Hot Stocks
Blizzard co-founder Frank Pearce departing after 28 years »

One of the founders of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 05

    Sep

NBSE

NeuBase Therapeutics

$3.55

-0.58 (-14.04%)

17:25
07/22/19
07/22
17:25
07/22/19
17:25
Hot Stocks
Carnegie Mellon reports 5.5% passive stake in NeuBase Therapeutics »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CADE

Cadence Bancorp

$15.86

-3.75 (-19.12%)

17:23
07/22/19
07/22
17:23
07/22/19
17:23
Downgrade
Cadence Bancorp rating change  »

Cadence Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 06

    Aug

  • 26

    Aug

  • 23

    Sep

CAL

Caleres

$18.27

0.27 (1.50%)

17:22
07/22/19
07/22
17:22
07/22/19
17:22
Hot Stocks
Caleres, Veronica Beard announce exclusive footwear partnership »

Caleres and Veronica…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

AAPL

Apple

$207.21

4.59 (2.27%)

, INTC

Intel

$51.36

1.1 (2.19%)

17:22
07/22/19
07/22
17:22
07/22/19
17:22
Periodicals
Breaking Periodicals news story on Apple, Intel »

Apple in advanced talks…

AAPL

Apple

$207.21

4.59 (2.27%)

INTC

Intel

$51.36

1.1 (2.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 30

    Jul

  • 03

    Aug

EFSC

Enterprise Financial

$39.39

-0.58 (-1.45%)

17:19
07/22/19
07/22
17:19
07/22/19
17:19
Earnings
Enterprise Financial reports Q2 EPS 98c, consensus 93c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

TTEC

TTEC Holdings

$47.31

0.04 (0.08%)

17:19
07/22/19
07/22
17:19
07/22/19
17:19
Syndicate
Breaking Syndicate news story on TTEC Holdings »

TTEC Holdings files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

TTEC

TTEC Holdings

$47.31

0.04 (0.08%)

17:18
07/22/19
07/22
17:18
07/22/19
17:18
Syndicate
Breaking Syndicate news story on TTEC Holdings »

TTEC Holdings files $350M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

VBTX

Veritex

$25.67

-0.44 (-1.69%)

17:17
07/22/19
07/22
17:17
07/22/19
17:17
Earnings
Veritex reports Q2 EPS 59c, consensus 62c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 26

    Aug

  • 23

    Sep

WM

Waste Management

$117.15

0.39 (0.33%)

17:12
07/22/19
07/22
17:12
07/22/19
17:12
Initiation
Waste Management initiated  »

Waste Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

IBTX

Independent Bank

$55.08

-1.08 (-1.92%)

17:05
07/22/19
07/22
17:05
07/22/19
17:05
Earnings
Independent Bank reports Q2 adjusted EPS $1.22, consensus $1.27 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 26

    Aug

  • 23

    Sep

RNST

Renasant

$34.10

-0.49 (-1.42%)

17:04
07/22/19
07/22
17:04
07/22/19
17:04
Earnings
Renasant reports Q2 EPS 80c with items, consensus 81c »

Reports Q2 net loan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 23

    Sep

STLD

Steel Dynamics

$31.55

0.09 (0.29%)

17:03
07/22/19
07/22
17:03
07/22/19
17:03
Hot Stocks
Steel Dynamics announces planned new flat roll steel mill site selection »

Steel Dynamics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 06

    Aug

BRO

Brown & Brown

$34.64

-0.11 (-0.32%)

17:02
07/22/19
07/22
17:02
07/22/19
17:02
Hot Stocks
Brown & Brown reports Q2 organic revenue up 3.9% »

Reports Q2 EBITDA margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

HAE

Haemonetics

$122.44

0.35 (0.29%)

17:02
07/22/19
07/22
17:02
07/22/19
17:02
Hot Stocks
Haemonetics updates financial reporting segments »

Haemonetics Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 06

    Aug

  • 05

    Sep

  • 09

    Sep

BRO

Brown & Brown

$34.64

-0.11 (-0.32%)

17:01
07/22/19
07/22
17:01
07/22/19
17:01
Earnings
Brown & Brown reports Q2 adjusted EPS 32c, consensus 28c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

DLX

Deluxe

$41.95

0.41 (0.99%)

17:00
07/22/19
07/22
17:00
07/22/19
17:00
Hot Stocks
Deluxe names Chris Thomas chief revenue officer »

Deluxe Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 19

    Sep

GE

General Electric

$10.22

0.18 (1.79%)

, AVCO

Avalon GloboCare

$2.05

-0.105 (-4.88%)

16:57
07/22/19
07/22
16:57
07/22/19
16:57
Hot Stocks
Avalon GloboCare and GE Healthcare announce strategic partnership »

Avalon GloboCare (AVCO)…

GE

General Electric

$10.22

0.18 (1.79%)

AVCO

Avalon GloboCare

$2.05

-0.105 (-4.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 09

    Sep

  • 09

    Sep

VIVE

Viveve

$0.41

-0.0155 (-3.68%)

16:55
07/22/19
07/22
16:55
07/22/19
16:55
Hot Stocks
Breaking Hot Stocks news story on Viveve 

Viveve trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VFF

Village Farms

$10.69

0.48 (4.70%)

16:53
07/22/19
07/22
16:53
07/22/19
16:53
Initiation
Village Farms initiated at Craig-Hallum »

Village Farms initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BBY

Best Buy

$75.72

0.995 (1.33%)

16:53
07/22/19
07/22
16:53
07/22/19
16:53
Hot Stocks
Best Buy beneficial owner Richard Schulze sells $32.4M in company shares »

Best Buy beneficial owner…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

ORGO

Organogenesis

$5.85

-0.27 (-4.41%)

16:50
07/22/19
07/22
16:50
07/22/19
16:50
Syndicate
Organogenesis commences exchange offer »

Organogenesis Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Aug

WD

Walker & Dunlop

$55.46

-0.39 (-0.70%)

16:49
07/22/19
07/22
16:49
07/22/19
16:49
Hot Stocks
Walker & Dunlop appoints Chief Production Officer to Lead FHA finance team »

Walker & Dunlop…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 15

    Aug

EQBK

Equity Bancshares

$24.43

-0.19 (-0.77%)

16:49
07/22/19
07/22
16:49
07/22/19
16:49
Earnings
Equity Bancshares reports Q2 EPS 58c, consensus 60c »

The net interest margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 23

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.